ciprofloxacin has been researched along with von Willebrand Diseases in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castaman, G | 2 |
Lattuada, A | 1 |
Mannucci, PM | 1 |
Rodeghiero, F | 2 |
2 other studies available for ciprofloxacin and von Willebrand Diseases
Article | Year |
---|---|
Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor.
Topics: Bleeding Time; Ciprofloxacin; Collagen; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Humans | 1995 |
Acquired transitory von Willebrand syndrome with ciprofloxacin.
Topics: Adult; Ciprofloxacin; Female; Humans; Male; von Willebrand Diseases | 1994 |